While TEAD4 activation by GC promoted breast cancer stem cell maintenance, cell survival, metastasis, and chemoresistance both in vitro and in vivo, it was also completely blocked by cotreatment with mifepristone [208]. Here, TEAD4 is linked to breast carcinoma.